Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Biosimilars
The Pharmacy Times® Biosimilars Resource Center is a comprehensive resource for clinical news and expert insights on issues related to biosimilar drugs, a biological product that is highly similar to a reference biologic for which there are no clinically meaningful differences in terms of safety, purity, and efficacy.
Latest News
Biosimilar of Xolair shows Similarity in Reducing Asthma Exacerbations
September 4th 2024
P043 is currently approved for patients 6 years and older with moderate to severe persistent allergic asthma whose disease is inadequately controlled with inhaled corticosteroids.
